NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Amphenol

(APH) - Get Report

downgraded at BofA/Merrill to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $65 price target.

Berkshire Hathaway (A shares)

(BRK.A) - Get Report

downgraded to hold at TheStreet Ratings.

Berkshire Hathaway (B shares)

(BRK.B) - Get Report

downgraded to hold at TheStreet Ratings.

Freescale Semi

(FSL)

rated new Neutral at UBS. $11.75 price target. Limited near term catalysts as turnaround in progress.

Globus Medical

(GMED) - Get Report

rated new Buy at Goldman. $18 price target. Company can deliver 13% annual sales growth and is reasonably valued.

Globus Medical rated new Outperform at Oppenheimer. $18 price target. Company is growing faster than its peers and expanding internationally.

GlaxoSmithKline

(GSK) - Get Report

downgraded at UBS to Neutral from Buy, UBS said. $48.18 price target. Valuation, earnings visibility limit potential for further upside.

KLA-Tencor

(KLAC) - Get Report

downgraded at Deutsche from Hold to Sell, Deutsche Bank said. $44 price target. Company is leveraged to lower foundry spending.

Pioneer Southwest

(PSE)

downgraded at UBS to Sell from Neutral, UBS said. $24 price target. Limited hedge book relative to peers.

STOCK COMMENTS / EPS CHANGES

Gilead

(GILD) - Get Report

estimates, target increased at Jefferies. GILD estimates were raised through 2013, Jefferies said. Stribild quad pill was approved with the FDA and the company announced higher pricing. Hold rating and new $55 price target.

Ingersoll-Rand

(IR) - Get Report

target raised at UBS to $54, UBS said. Several potential catalysts including improving HVAC business conditions. Buy rating.

M&T Bank

(MTB) - Get Report

numbers boosted at Credit Suisse. Shares of MTB now seen reaching $102, according to Credit Suisse. Estimates also upped, as the HCBK acquisition should add to earnings. Neutral rating.

PVH

(PVH) - Get Report

estimates, target raised at Brean. Shares of PVH now seen reaching $115, according to Brean Murray. Estimates also increased, as the company is seeing better growth across the board. Buy rating.

Rackspace

(RAX)

target boosted at JMP. Shares of RAX now seen reaching $65, according to JMP Securities. Company can continue to grow through its potential inclusion in the OpenStack Foundation. Outperform rating.

VMWare

(VMW) - Get Report

target raised at ThinkEquity to $105. Company can create a true enterprise datacenter destination. Buy rating.

>To submit a news tip, email:

tips@thestreet.com

.

READERS ALSO LIKE:

>>2012 Biotech Stock Predictions - An Interim Report Card

>>Beneath Apple's Pyrrhic Patent Victory

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.